Exchange: OTC·Updated 05:10 PM EDT

About

Medexus Pharmaceuticals, Inc. engages in the licensing, acquisition, development, and commercialization of specialty pharmaceutical products in the United States and Canada. The company focuses on therapeutic areas including hematology, hematology-oncology, rheumatology, and allergy. Its principal commercial products include GRAFAPEX, IXINITY, Rasuvo, Metoject, Rupall, and Trecondyv. The company was founded in 2003 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
90

Frequently Asked Questions

What is Market Cap of Medexus Pharmaceuticals Inc?
What is the 52-week high for Medexus Pharmaceuticals Inc?
What is the 52-week low for Medexus Pharmaceuticals Inc?
What is Medexus Pharmaceuticals Inc stock price today?
What was Medexus Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Medexus Pharmaceuticals Inc?
What is the Price-to-Book ratio of Medexus Pharmaceuticals Inc?
What is the 50-day moving average of Medexus Pharmaceuticals Inc?
How many employees does Medexus Pharmaceuticals Inc have?

Advertisement|Remove ads.